Target intelligence / Profile preview

Novel transcript, antisense to PAX5

Molecular classification
Other (Long non-coding RNA, antisense RNA)
01

Overview

This molecule is a long non-coding RNA (lncRNA) transcribed antisense to the PAX5 gene. It does not code for a protein and is not itself a direct therapeutic target such as a receptor, enzyme, or transporter. Antisense lncRNAs can regulate the expression of the corresponding sense gene through various mechanisms (transcriptional interference, RNA duplex formation, epigenetic modification), but there is no direct evidence in the literature for this particular transcript’s function, disease association, or drug interactions. Its annotation as "novel transcript, antisense to PAX5" suggests it was discovered via transcriptomics and has not yet been characterized in detail. Notes on correctness: - This entry is not a traditional therapeutic target (not a receptor, enzyme, transporter, etc.), and the label "novel transcript, antisense to PAX5" is descriptive rather than a standardized gene or protein name. - It may be incorrectly used as a therapeutic target without additional characterization. - No specific molecular, biomarker, or drug information is available for this transcript in current literature or databases. If you require information on PAX5 itself (Paired box protein Pax-5), that is a well-studied transcription factor and a bona fide therapeutic/disease target, but the described entry here is the antisense lncRNA, not PAX5 protein.

Other names
lncRNA antisense to PAX5PAX5-AS (unofficial, if encountered)ENSG00000305240
02

Biological functions

Potential regulation of PAX5 gene expression (by analogy to other antisense lncRNAs, but not specifically demonstrated for this transcript)
03

Disease associations

Possible relevance to cancer or neurological/immune diseases if it regulates PAX5, but direct evidence is lacking for this specific transcript

Beyond the preview

Go deeper on Novel transcript, antisense to PAX5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to PAX5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call